# Quality of life outcomes in colorectal cancer survivors: insights from an analytical study at a tertiary cancer center-Qatar

**Authors:** Nada Adli, Mohammed Adil Arbab Ahmed, Nahlah AlMesbah, Nagah Selim, Mohamed Abdelsalam Elimam Ibrahim, Sujood Abdulwakeel Musa Awadelseed, Mohamed Iheb Bougmiza, Hadi Mohamad Abu Rasheed, Kakil Rasul

PMC · DOI: 10.3389/fonc.2025.1730212 · Frontiers in Oncology · 2026-02-11

## TL;DR

This study examines the quality of life of colorectal cancer survivors in Qatar, finding that socioeconomic factors significantly impact their well-being.

## Contribution

The study provides new insights into QoL determinants among CRC survivors in Qatar, emphasizing the role of socioeconomic status.

## Key findings

- CRC patients in Qatar reported moderate to high global quality of life despite advanced disease stages.
- Financial difficulties and fatigue were the most reported concerns among participants.
- Higher income and longer time since diagnosis were associated with better functional quality of life.

## Abstract

Colorectal cancer (CRC) is a major public health concern that affects patients’ quality of life (QoL) and imposes challenges on families and healthcare systems.

To assess QoL and its determinants among CRC patients in Qatar and identify sociodemographic and clinical factors influencing QoL in 2023.

An analytical cross-sectional study was conducted between July and December 2023. From the National Center for Cancer Care and Research (NCCCR) registry, 456 CRC patients were screened, and 169 eligible participants were included. QoL was evaluated using the EORTC QLQ-C30 and the CRC-specific QLQ-CR29 tools.

Most patients were aged ≥45 years (80.5%), non-Qatari (79.9%), and married (88.8%). Hypertension (39.1%) and diabetes (31.4%) were the most common comorbidities. Adenocarcinoma was predominant (90.5%), with most cases diagnosed at advanced stages (III–IV, 74.8%) and metastasis in 71.6%. The sigmoid colon was the most common site (34.9%), and combined surgery and chemotherapy were the main treatments (69.2%). Global QoL was moderate to high (70.4 ± 18.5), with fatigue (23.9 ± 26.8) and financial difficulties (28.9 ± 40.4) as the most reported concerns. Functional QoL was higher among those with sufficient income (+12.5 points, p < 0.01) and longer time since diagnosis (+0.06 points/month, p < 0.05), but lower among those with higher education (–5.0 points, p = 0.05) or alcohol use (–11.2 points, p = 0.05).

Despite advanced disease stages, CRC patients in Qatar reported good QoL. Socioeconomic status significantly influenced outcomes, highlighting the need for integrated psychosocial and financial support.

## Linked entities

- **Diseases:** colorectal cancer (MONDO:0005575), diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** TENM1 (teneurin transmembrane protein 1) [NCBI Gene 10178] {aka ODZ1, ODZ3, TEN-M1, TEN1, TNM, TNM1}
- **Diseases:** vomiting (MESH:D014839), financial difficulties (MESH:D051346), diarrhea (MESH:D003967), fatigue (MESH:D005221), nausea (MESH:D009325), anxiety (MESH:D001007), rectal tumors (MESH:D012004), chronic kidney or liver disease (MESH:D051436), flatulence (MESH:D005414), Cancer (MESH:D009369), Adenocarcinoma (MESH:D000230), diabetes (MESH:D003920), sexual dysfunction (MESH:D012735), dyspnea (MESH:D004417), insomnia (MESH:D007319), cognitive or psychiatric disorders (MESH:D001523), respiratory disease (MESH:D012140), pain (MESH:D010146), sleep disturbances (MESH:D012893), constipation (MESH:D003248), appetite loss (MESH:D001068), breast cancer (MESH:D001943), depression (MESH:D003866), neuroendocrine carcinoma (MESH:D018278), CR 29 (OMIM:614890), immune disorders (MESH:D007154), gastrointestinal complaints (MESH:D005767), urinary disturbances (MESH:D014548), cardiovascular disease (MESH:D002318), CRC (MESH:D015179), deaths (MESH:D003643), Hypertension (MESH:D006973), NOS (MESH:C536665), metastases (MESH:D009362), Symptom (MESH:D012816)
- **Chemicals:** Alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933197/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933197/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933197/full.md

---
Source: https://tomesphere.com/paper/PMC12933197